Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care

Objectives: The hypothesis of this study is that tocilizumab should affect common signs of infection due to its immunosuppressive properties. Primary aim of the study was to investigate whether the administration of tocilizumab to critically ill patients with COVID-19, led to a different clinical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Taramasso, Lucia, Magnasco, Laura, Portunato, Federica, Briano, Federica, Vena, Antonio, Giacobbe, Daniele R., Dentone, Chiara, Robba, Chiara, Ball, Lorenzo, Loconte, Maurizio, Patroniti, Nicolò, Frisoni, Paolo, D'Angelo, Raffaele, Dettori, Silvia, Mikulska, Malgorzata, Pelosi, Paolo, Bassetti, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403658/
https://www.ncbi.nlm.nih.gov/pubmed/34511338
http://dx.doi.org/10.1016/j.ejim.2021.08.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403658/
https://www.ncbi.nlm.nih.gov/pubmed/34511338
http://dx.doi.org/10.1016/j.ejim.2021.08.020

Ejemplares similares